SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-257696
Filing Date
2023-10-17
Accepted
2023-10-17 16:31:53
Documents
13
Period of Report
2023-10-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d561275d8k.htm   iXBRL 8-K 24883
2 EX-99.1 d561275dex991.htm EX-99.1 43188
  Complete submission text file 0001193125-23-257696.txt   200292

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20231012.xsd EX-101.SCH 2867
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20231012_lab.xml EX-101.LAB 17237
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20231012_pre.xml EX-101.PRE 10824
7 EXTRACTED XBRL INSTANCE DOCUMENT d561275d8k_htm.xml XML 3225
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 231329944
SIC: 3841 Surgical & Medical Instruments & Apparatus